Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Enovis Corp (ENOV)

Enovis Corp (ENOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,409,330
  • Shares Outstanding, K 55,875
  • Annual Sales, $ 1,707 M
  • Annual Income, $ -33,260 K
  • EBIT $ 43 M
  • EBITDA $ 260 M
  • 60-Month Beta 1.94
  • Price/Sales 1.39
  • Price/Cash Flow 6.64
  • Price/Book 0.71

Options Overview Details

View History
  • Implied Volatility 48.12% ( -1.32%)
  • Historical Volatility 28.20%
  • IV Percentile 82%
  • IV Rank 57.42%
  • IV High 68.07% on 10/16/24
  • IV Low 21.22% on 05/16/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1,024
  • Volume Avg (30-Day) 94
  • Put/Call OI Ratio 2.18
  • Today's Open Interest 10,865
  • Open Int (30-Day) 10,546

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.92
  • Number of Estimates 4
  • High Estimate 0.95
  • Low Estimate 0.90
  • Prior Year 0.79
  • Growth Rate Est. (year over year) +16.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.71 +3.38%
on 12/19/24
49.75 -13.33%
on 12/04/24
-1.66 (-3.71%)
since 11/20/24
3-Month
38.27 +12.67%
on 10/08/24
49.83 -13.47%
on 11/06/24
-0.55 (-1.26%)
since 09/20/24
52-Week
38.27 +12.67%
on 10/08/24
65.03 -33.69%
on 02/22/24
-11.84 (-21.54%)
since 12/20/23

Most Recent Stories

More News
Enovis Corporation Management to Participate in Upcoming Investor Conferences

Enovis Corporation executives will present at upcoming investor conferences, discussing their innovative medical technology solutions.Quiver AI SummaryEnovis Corporation, a medical technology growth company,...

ENOV : 43.12 (+1.48%)
Enovis to Participate in Upcoming Investor Conferences

ENOV : 43.12 (+1.48%)
Enovis: Q3 Earnings Snapshot

Enovis: Q3 Earnings Snapshot

ENOV : 43.12 (+1.48%)
Enovis Announces Third Quarter 2024 Results

ENOV : 43.12 (+1.48%)
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

ENOV : 43.12 (+1.48%)
Enovis: Q2 Earnings Snapshot

Enovis: Q2 Earnings Snapshot

ENOV : 43.12 (+1.48%)
EQT PRIVATE EQUITY TO SELL LIMACORPORATE TO ENOVIS: THE ITALIAN SITE IN SAN DANIELE DEL FRIULI WILL REMAIN THE FULCRUM OF PRODUCTION, BENEFITING FROM NEW INVESTMENTS

/PRNewswire/ -- EQT Private Equity announces the sale of LimaCorporate to Enovis. With this transaction, LimaCorporate will become part of the NYSE-listed...

ENOV : 43.12 (+1.48%)
Enovis Announces Second Quarter 2022 Results

Sales of $395 million include 11% reported growth, 3% organic growth and 5% sales-per-day growthReported operating income of $6 million, while...

ENOV : 43.12 (+1.48%)
Enovis Launches ARVIS®, Only Augmented Reality Surgical Guidance System Designed Specifically to Improve Both Total Hip and Knee Replacement Surgery

Today, Enovis (NYSE: ENOV), an innovation-driven medical technology company, announced the commercial launch of ARVIS ® (Augmented Reality Visualization and Information System) with over 200 cases...

ENOV : 43.12 (+1.48%)
Enovis to Host Second Quarter 2022 Conference Call on August 4th

Wilmington, DE, July 12, 2022 (GLOBE NEWSWIRE) -- Enovisâ„¢ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced...

ENOV : 43.12 (+1.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.

See More

Key Turning Points

3rd Resistance Point 45.37
2nd Resistance Point 44.48
1st Resistance Point 43.80
Last Price 43.12
1st Support Level 42.23
2nd Support Level 41.34
3rd Support Level 40.66

See More

52-Week High 65.03
Fibonacci 61.8% 54.81
Fibonacci 50% 51.65
Fibonacci 38.2% 48.49
Last Price 43.12
52-Week Low 38.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar